BOSTON–(BUSINESS WIRE)– #YesCCT–Elucid, a medical technology company using AI-powered, clinically validated software to advance precision diagnosis of cardiovascular disease, today announced that Mark Miller has joined the company as chief revenue officer (CRO). Miller will sit on Elucid’s leadership team and report directly to CEO Kelly Huang, PhD. He joins the company ahead of the launch of its comprehensive cardiovascular platform, which is comprised of its FDA-cleared Plaque-IQ™ and its BioIntegra
See full post here as originally published on this site
